Loading...
XSHG603360
Market cap1.45bUSD
Dec 24, Last price  
21.85CNY
1D
-0.36%
1Q
62.70%
IPO
309.18%
Name

Dalian BIO-CHEM Co Ltd

Chart & Performance

D1W1MN
XSHG:603360 chart
P/E
32.25
P/S
9.94
EPS
0.68
Div Yield, %
1.95%
Shrs. gr., 5y
6.26%
Rev. gr., 5y
15.07%
Revenues
1.07b
-15.20%
208,554,425256,548,288291,377,906346,635,810327,991,416389,433,985410,364,502528,171,162871,896,072749,541,0311,006,261,5061,256,659,9121,065,660,659
Net income
328m
-18.43%
41,906,37544,810,67248,920,50864,032,31957,338,55498,273,387100,266,398145,187,507306,801,352221,754,543250,491,543402,565,517328,375,064
CFO
390m
-18.80%
39,846,99419,019,40053,842,96659,513,77274,035,564119,767,90276,038,489135,131,582240,066,206210,615,284142,025,131479,900,179389,685,710
Dividend
May 31, 20240.84 CNY/sh
Earnings
May 16, 2025

Profile

Dalian BIO-CHEM Company Limited produces and sells bactericides, antiseptics, and fungicides for various industrial applications in Europe, North and South Americas, the Middle East, Africa, and Asia. The company's products are used as disinfection; algaecide in water treatment, such as petrochemicals, electricity, central air conditioning, and industrial cooling water; anti-corrosion in emulsions, mineral slurries, pigment dispersions, adhesives, tackifiers, metalworking fluids, and cosmetics aqueous system; and aqueous system of leather, paint and coating, textile, and dyeing. Its products also used for anti-mildew and anti-algae applications, as well as manufactures dry film preservative, which is used for paints and coatings. Dalian BIO-CHEM Company Limited was founded in 2003 and is based in Dalian, China.
URL
http://www.biofc.com
IPO date
Feb 06, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,065,661
-15.20%
1,256,660
24.88%
1,006,262
34.25%
Cost of revenue
680,275
698,527
649,090
Unusual Expense (Income)
NOPBT
385,386
558,133
357,171
NOPBT Margin
36.16%
44.41%
35.49%
Operating Taxes
57,403
58,867
41,548
Tax Rate
14.89%
10.55%
11.63%
NOPAT
327,983
499,266
315,623
Net income
328,375
-18.43%
402,566
60.71%
250,492
12.96%
Dividends
(206,862)
(150,143)
Dividend yield
3.96%
4.55%
Proceeds from repurchase of equity
(768)
BB yield
0.01%
Debt
Debt current
150,012
129,113
338,505
Long-term debt
763
Deferred revenue
9,342
10,628
37,325
Other long-term liabilities
1
10,000
Net debt
(395,764)
(303,323)
42,777
Cash flow
Cash from operating activities
389,686
479,900
142,025
CAPEX
(67,352)
Cash from investing activities
(126,920)
Cash from financing activities
(188,161)
FCF
56,290
408,809
(30,465)
Balance
Cash
599,538
417,963
294,507
Long term investments
(52,999)
14,474
1,221
Excess cash
493,257
369,603
245,415
Stockholders' equity
1,410,437
1,466,700
1,057,478
Invested Capital
1,303,198
1,228,075
1,188,017
ROIC
25.91%
41.33%
30.45%
ROCE
21.15%
34.05%
24.29%
EV
Common stock shares outstanding
494,328
334,784
354,230
Price
10.57
-15.78%
12.55
34.80%
9.31
-14.59%
Market cap
5,225,048
24.36%
4,201,538
27.40%
3,297,886
-17.16%
EV
4,829,283
3,898,215
3,340,663
EBITDA
449,347
629,061
405,307
EV/EBITDA
10.75
6.20
8.24
Interest
5,316
3,717
11,767
Interest/NOPBT
1.38%
0.67%
3.29%